Giner, M.; Vázquez-Gámez, M.A.; Miranda, M.J.; Bocio-Nuñez, J.; Olmo-Montes, F.J.; Rico, M.A.; Colmenero, M.A.; Montoya-GarcÃa, M.-J.
Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment. J. Clin. Med. 2022, 11, 4749.
https://doi.org/10.3390/jcm11164749
AMA Style
Giner M, Vázquez-Gámez MA, Miranda MJ, Bocio-Nuñez J, Olmo-Montes FJ, Rico MA, Colmenero MA, Montoya-GarcÃa M-J.
Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment. Journal of Clinical Medicine. 2022; 11(16):4749.
https://doi.org/10.3390/jcm11164749
Chicago/Turabian Style
Giner, Mercè, MarÃa Angeles Vázquez-Gámez, MarÃa José Miranda, Jesús Bocio-Nuñez, Francisco Jesús Olmo-Montes, Miguel Angel Rico, Miguel Angel Colmenero, and MarÃa-José Montoya-GarcÃa.
2022. "Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment" Journal of Clinical Medicine 11, no. 16: 4749.
https://doi.org/10.3390/jcm11164749
APA Style
Giner, M., Vázquez-Gámez, M. A., Miranda, M. J., Bocio-Nuñez, J., Olmo-Montes, F. J., Rico, M. A., Colmenero, M. A., & Montoya-GarcÃa, M.-J.
(2022). Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment. Journal of Clinical Medicine, 11(16), 4749.
https://doi.org/10.3390/jcm11164749